Expression and replication timing patterns of wildtype and translocated BCL2 genes

Genomics

Volumn 73, Issue 2, 2001, Pages 161-170

  Sun, Yujie ^a   Wyatt, Richard T ^b   Bigley, Anne ^a   Krontiris, Theodore G ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ALLELE; ARTICLE; CARCINOGENESIS; CELL CYCLE PHASE; CHROMOSOME 14; CHROMOSOME 18; CONTROLLED STUDY; DNA STRAND BREAKAGE; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE REPLICATION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0035870554     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6479     Document Type: Article

References (46)

1. Trinucleotide repeat expansion and human disease
2. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
3. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
4. The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements
5. Circular YAC vectors containing a small mammalian origin sequence can associate with the nuclear matrix
6. Activation and repression of a beta-globin gene in cell hybrids is accompanied by a shift in its temporal replication
7. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition
8. The BCL2 major breakpoint region is a sequence- and cell-cycle-specific binding site of the Ku antigen
9. Analysis of the attachment of replicating DNA to a nuclear matrix in mammalian interphase nuclei
10. Matrix attachment regions are positioned near replication initiation sites, genes, and an interamplicon junction in the amplified dihydrofolate reductase domain of Chinese hamster ovary cells
11. Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: Evidence for different regulation
12. Asynchronous DNA replication within the human beta-globin gene locus
13. Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions
14. Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions
15. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
16. Replication timing of genes and middle repetitive sequences
17. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells
18. Reverse replication timing for the XIST gene in human fibroblasts
19. FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis
20. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
21. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death
22. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain
23. Extension of chromatin accessibility by nuclear matrix attachment regions
24. Allele-specific replication timing in imprinted domains: Absence of asynchrony at several loci
25. Allele-specific replication timing of imprinted gene regions
26. Translocations among antibody genes in human cancer
27. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
28. Mutation detection by PCR, GC-clamps, and denaturing gradient gel electrophoresis
29. Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions
30. Attachment to the nuclear matrix mediates specific alterations in chromatin structure
31. Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation
32. Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2
33. Alternative promoters and exons, somatic mutation and deregulation of the bcl-2-lg fusion gene in lymphoma
34. Genetic transfer and expression of reconstructed yeast artificial chromosomes containing normal and translocated BCL2 proto-oncogenes
35. Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation
36. The molecular basis of fragile sites in human chromosomes
37. Translocations and amplification of the BCL2 gene are detected in interphase nuclei of non-Hodgkin's lymphoma by in situ hybridization with yeast artificial chromosome clones
38. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells
39. Cloning of the chromosome breakpoint of neoplastic b cells with the t(14;18) chromosome translocation
40. Involvement of the bcl-2 gene in human follicular lymphoma
41. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining
42. Expression of H19 does not influence the timing of replication of the Igf2/H19 imprinted region
43. Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal antibodies and cytochemical techniques
44. BCL2 oncogene translocation is mediated by a chi-like consensus
45. Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat